Literature DB >> 6119203

A comparison between propranolol, practolol and betaxolol (SL75212) on the circulatory and metabolic responses to insulin-induced hypoglycaemia.

J Saunders, R Gomeni, J R Kilborn, P L Morselli, P H Sönksen.   

Abstract

1. Six healthy male volunteers received equivalent intravenous beta-blocking doses of propranolol, practolol and betaxolol (SL75212) or saline at weekly intervals Sixty minutes later 0.1 unit/kg insulin was given intravenously. 2. In all studies, maximum hypoglycaemia (mean 1.2 mmol/l) was reached thirty minutes after insulin. Recovery from hypoglycaemia was delayed with propranolol but practolol and betaxolol had no effect. 3. Propranolol blocked the tachycardia and widening of pulse pressure seen in saline treated subjects. It also blocked the rebound rise in free fatty acids (FFA) and glycerol concentrations that followed the nadir of hypoglycaemia. 4. Neither practolol nor betaxolol had significant effects on pulse rate or blood pressure but betaxolol resembled propranolol in blocking the rebound rise in FFA and glycerol, while practolol blocked the rise in glycerol alone. 5. The magnitude of the rise in growth hormone following hypoglycaemia was similar in all groups, but the peak was earlier after practolol and betaxolol.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6119203     DOI: 10.1007/bf00627917

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  41 in total

1.  IGPHARM: interactive graphic package for pharmacokinetic analysis.

Authors:  C Gomeni; R Gomeni
Journal:  Comput Biomed Res       Date:  1978-08

2.  Blockade of isoprenaline-induced changes in plasma free fatty acids, immunoreactive insulin levels and plasma renin activity in healthy human subjects, by propranolol, pindolol, practolol, atenolol, metoprolol and acebutolol.

Authors:  H H Harms; L Gooren; A J Spoelstra; C Hesse; L Verschoor
Journal:  Br J Clin Pharmacol       Date:  1978-01       Impact factor: 4.335

3.  Comparison of atenolol and propranolol during insulin-induced hypoglycaemia.

Authors:  S P Deacon; D Barnett
Journal:  Br Med J       Date:  1976-07-31

4.  Effects of propranolol on the hormonal and metabolic responses to insulin-induced hypoglycaemia.

Authors:  E A Abramson; R A Arky; K A Woeber
Journal:  Lancet       Date:  1966-12-24       Impact factor: 79.321

5.  Receptor mechanisms in the hyperglycaemic response to adrenaline in man.

Authors:  A Antonis; M L Clark; R L Hodge; M Molony; T R Pilkington
Journal:  Lancet       Date:  1967-05-27       Impact factor: 79.321

6.  The spectrofluorimetric estimation and buccal absorption of SL 75212, a novel beta-adrenoceptor antagonist [proceedings].

Authors:  B J Davis; P Turner
Journal:  Br J Clin Pharmacol       Date:  1979-10       Impact factor: 4.335

7.  Comparison of hormonal and metabolic effects of salbutamol infusion in normal subjects and insulin-requiring diabetics.

Authors:  A S Gündogdu; P M Brown; S Juul; L Sachs; P H Sönksen
Journal:  Lancet       Date:  1979 Dec 22-29       Impact factor: 79.321

8.  Observations in man of hypoglycaemia during selective and non-selective beta-blockade.

Authors:  N M Davidson; R J Corrall; T R Shaw; E B French
Journal:  Scott Med J       Date:  1977-01       Impact factor: 0.729

9.  Effect of cardioselective and non-selective beta-blockade on the hypoglycaemic response in insulin-dependent diabetics.

Authors:  I Lager; G Blohmé; U Smith
Journal:  Lancet       Date:  1979-03-03       Impact factor: 79.321

10.  Cortisol, growth hormone and prolactin responses to insulin-induced hypoglycaemia in hyperthyroid patients before and during beta-adrenoceptor blockade.

Authors:  O R Nilsson; B Anderberg; B E Karlberg; B Kågedal
Journal:  Clin Endocrinol (Oxf)       Date:  1980-06       Impact factor: 3.478

View more
  5 in total

1.  The effects of chronic dosing on the beta 1 and beta 2-adrenoceptor antagonism of betaxolol and atenolol.

Authors:  B J Lipworth; N A Irvine; D G McDevitt
Journal:  Eur J Clin Pharmacol       Date:  1991       Impact factor: 2.953

2.  The effects of time and dose on the relative beta 1- and beta 2-adrenoceptor antagonism of betaxolol and atenolol.

Authors:  B J Lipworth; N A Irvine; D G McDevitt
Journal:  Br J Clin Pharmacol       Date:  1991-02       Impact factor: 4.335

3.  Betaxolol and glucose-insulin relationships: studies in normal subjects taking glibenclamide or metformin.

Authors:  A J Sinclair; I B Davies; S J Warrington
Journal:  Br J Clin Pharmacol       Date:  1990-11       Impact factor: 4.335

4.  A dose-ranging study to evaluate the beta-adrenoceptor selectivity of single doses of betaxolol.

Authors:  N A Irvine; B J Lipworth; D G McDevitt
Journal:  Br J Clin Pharmacol       Date:  1990-07       Impact factor: 4.335

5.  Beta-adrenoceptor blockade and hypoglycaemia. A randomised, double-blind, placebo controlled comparison of metoprolol CR, atenolol and propranolol LA in normal subjects.

Authors:  D Kerr; I A MacDonald; S R Heller; R B Tattersall
Journal:  Br J Clin Pharmacol       Date:  1990-06       Impact factor: 4.335

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.